Encouraging results of corona virus vaccine developed by Oxford scientists

Oxford: A long-awaited vaccine developed by Oxford scientists for the coronavirus has yielded positive results and a security response.

A total of 1,077 people were vaccinated in the first trial, and after being vaccinated, their bodies began to produce large amounts of antibodies and T cells against the corona virus. Despite cautious estimates, experts have described it as an extraordinarily promising achievement.

Although it will take time for the whole situation to become clear, the British government has ordered the development of 100 million such vaccines.

Vaccine introduction and procedure

The vaccine has been a big name in ChAdOx1 nCoV-19, it has been developed by experts at lightning speed. These chimpanzees have had to change the virus with the help of genetic engineering to people suffering from the common cold. The virus is causing a great deal of trouble and the reason is that Corinna has become a map of the virus.

Scientists have incorporated the genetic information of the protein of the corona virus into the cold disease virus for vaccine making because the same protein attacks human cells and makes them sick.

This clearly means that the vaccine became like the common corona virus and the human immune system (natural defense) attacked it as an enemy and in the process the body naturally started producing T cells and antibodies.

What are antibodies and T cells?

In the fight against the corona virus, we have focused on antibodies, but this is only a small part of the security defense against the disease.

Remember that antibodies are small proteins that cling to the surface of the virus. Antibodies can kill the corona virus.

T cells, on the other hand, are white blood cells that communicate with the immune system and detect which cells in the body are infected.

T cells then destroy the affected cell. That is why every good vaccine contains both antibodies and T cells that fight the disease.

When patient samples were taken after vaccination, the number of T cells reached its highest level only 14 days after vaccination. Similarly, 28 days later, the antibody level graph was at its peak. But the study did not give much time to determine how long the series could last.

Professor Andrew Pollard, head of the Oxford Research Group, praised the success, saying both T cells and antibodies had been shown to be effective.

Is this vaccine safe?

The answer is that the vaccine may appear to be completely safe, but there may be some side effects. Seventy percent of the volunteers reported fever and headache, but no complications were reported. For this, experts have suggested taking paracetamol.

But experts say the vaccine will take longer and patients will be monitored for a longer period of time. Then there will be an effort to make it suitable for all human beings.

In the next phase, the vaccine will be tested on another 1,000 people.